Hsin‐Yuan Cheng - Concepedia

Author

Hsin‐Yuan Cheng

Allogene Therapeutics (United States)

Also Known As

Cheng, Hsin-Yuan, Hsin-Yuan Cheng, Hsinyuan Cheng, Hsin‐Yuan Cheng

Publications

440

Citations

H-Index

Concepts

All Affiliations

Allogene Therapeutics (United States)La Jolla Institute for Immunology National Taiwan University Hospital National Taiwan University

About

Hsin‐Yuan Cheng is an author at Allogene Therapeutics (United States) specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	245
2	Cell Biology	5	5	208
3	Cellular Physiology	2	2	67
4	Natural Sciences	1	1	22
5	Clinical Immunology	1	1	36

Hsin‐Yuan Cheng

Publications

434

Citations

H-Index

Page 1

	Year	Citations
Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis Hsin‐Yuan Cheng, Dalia E. Gaddis, Runpei Wu, Journal of Clinical Investigation Vascular DiseaseLymphocyte DevelopmentT-regulatory CellImmune RegulationImmunology	2016	83
Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery Cesar Sommer, Hsin‐Yuan Cheng, Duy Nguyen, Molecular Therapy	2020	82
Individual Heterogeneity in Platelet Response to Lysophosphatidic Acid Zehra Pamuklar, Jin Sun Lee, Hsin‐Yuan Cheng, Arteriosclerosis Thrombosis and Vascular Biology	2008	45
Increased Cholesterol Content in Gammadelta (γδ) T Lymphocytes Differentially Regulates Their Activation Hsin‐Yuan Cheng, Runpei Wu, Abraham K. Gebre, PLoS ONE ImmunologyImmune RegulationImmunologic MechanismCellular PhysiologyT Lymphocytes Differentially	2013	43
COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade Kyle Hansen, Sandeep Kumar, Kathryn Logronio, Cancer Immunology Immunotherapy Cancer ImmunosurveillancePd-1 Pathway BlockadeImmunologyImmune Checkpoint InhibitorNovel Therapeutic Antibody	2021	37
Gammadelta (γδ) T lymphocytes do not impact the development of early atherosclerosis Hsin‐Yuan Cheng, Runpei Wu, Catherine C. Hedrick Atherosclerosis InflammationClinical ImmunologyVascular DiseaseLymphocyte DevelopmentImmunology	2014	36
Molecular Identification of Canine Podocalyxin-Like Protein 1 as a Renal Tubulogenic Regulator Hsin‐Yuan Cheng, Yuyu Lin, Chunying Yu, Journal of the American Society of Nephrology Renal PathologyRenal InflammationNephrologyCellular PhysiologyMdck Cells	2005	24
An ecdysone and tetracycline dual regulatory expression system for studies on Rac1 small GTPase-mediated signaling Jen-Feng Lai, Shin‐Hun Juang, Yi‐Mei Hung, American Journal of Physiology-Cell Physiology Systems BiologySignal TransductionCell RegulationMolecular PathwayReporter Gene Assay	2003	22
Constitutive Turbodomains enhance expansion and antitumor activity of allogeneic BCMA CAR T cells in preclinical models Regina Lin, Janette Sutton, Trevor Bentley, Science Advances	2023	17
Doxycycline‐ and tetracycline‐regulated transcriptional silencer enhance the expression level and transactivating performance of rtTA Jen‐Feng Lai, Hsin‐Yuan Cheng, Tzu‐Ling Cheng, The Journal of Gene Medicine	2004	13

Page 1